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Abstract Our objective was to compare the results of
ambulatory hysteroscopy in postmenopausal women
with and without uterine bleeding. A retrospective
descriptive study was carried out on 236 women who
were at least 2 years into the menopause, who were not
undergoing hormone treatment and who had had
abnormal pelvic ultrasound results. Of these women, 150
were asymptomatic and 86 reported haemorrhage.
Diagnostic and operative outpatient hysteroscopy was
performed between January 2002 and December 2003.
There was no diﬀerence between the two groups
regarding age of patients, age of menopause and pres-
ence of at least one of the risk factors for endometrial
carcinoma evaluated, although obesity was more fre-
quent in the symptomatic group. Abnormal ultrasound
results for these women corresponded in the majority of
cases to intracavitary disease, and the absence of organic
endometrial pathology was 9.3% vs 11.3% in each
group. The more frequent pathology was benign endo-
metrial polyps (64% in bleeding patients and 84.7% in
asymptomatic ones). Endometrial carcinoma was diag-
nosed in 23.3% of women with metrorrhagia and in
1.3% of asymptomatic women. We diagnosed 2.6% of
malignancy inside polyps. Hysteroscopy results were
conﬁrmed by histology in 90.3% of cases. See and treat
in one session was achieved in 91% of benign endome-
trial polyps. Ambulatory hysteroscopy has high sensi-
tivity and speciﬁcity for intracavitary pathology and
high tolerability and safety. See and treat in one session
can be achieved in the majority of lesions with indication
for excision. These results make us advise our
menopausal patients with abnormal uterine bleeding to
undergo diagnostic hysteroscopy complemented with
biopsy.
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Introduction
Hysteroscopy has become the gold standard for the
evaluation of uterine cavity, providing correct diagnosis
through guided biopsies. Developments in endoscopy
technology have enabled us to oﬀer methods of diag-
nosis and treatment that are more accurate, eﬃcient and
easy to use. The new generation of hysteroscopes com-
bine miniaturization with excellent image resolution and
surgical ability. The use of ﬁve French bipolar electrodes
working in normal saline solution, like the Versapoint
from Gynecare, allows most of the pathology to be
safely diagnosed and the condition operated on at one
outpatient session [1, 2].
It has been estimated that between 10% and 15% of
women with postmenopausal uterine bleeding have
endometrial carcinoma or a premalignant disease of the
endometrium [3, 4]. The incidence of malignant endo-
metrial polyps ranges from 0.5% to 4.8% in the litera-
ture [5].
Transvaginal ultrasonography has been used as a
screening tool for detection of endometrial pathology in
postmenopausal women. In patients with abnormal
uterine bleeding it has demonstrated a sensitivity of 0.96
and a speciﬁcity of 0.89 [6].
Sonography results should always be obtained before
further diagnostic evaluation of the uterine cavity is
recommended [7]. In our setting the most frequent
indication for ambulatory hysteroscopy in menopause
are abnormal results of sonograms done routinely; that
is, with endometrial thickness above 4 mm, or other
intracavitary images, despite an absence of symptoms.
The purpose of this study was to compare the results
of ambulatory hysteroscopy in two groups of postmen-
opausal women: those with complaints of uterine
bleeding and those who were asymptomatic, all with
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abnormal sonogram results. Our aim was to evaluate (1)
the relation between metrorrhagia in menopause and
endometrial disease and (2) the role of transvaginal
ultrasonography as a screening method in the detection
of uterine cavity pathology in postmenopausal women,
even asymptomatic women.
Materials and methods
A retrospective analysis was carried out of ambulatory
hysteroscopies done from January 2002 to December
2003 in selected women. The setting was an ambulatory
unit of a university-aﬃliated central teaching hospital.
There were three inclusion criteria:
1. Women who were at least 2 years into the menopause
2. The absence of hormone therapy (e.g. tamoxifen,
oestrogen and progestin) during the past 2 years
3. Previous transvaginal ultrasonography
The study population consisted of 236 menopausal
women who had undergone diagnostic or surgical
hysteroscopy: 86 with history of uterine bleeding and
150 asymptomatic. Group 1 comprised symptomatic
women, and the group 2 women were asymptomatic. All
women had had abnormalities on ultrasound evaluation.
In terms of cut-oﬀ level for endometrial thickness we
advise hysteroscopy when this is more than 4 mm.
Sonograms were done in several centres, all in 2D
technology.
The parameters evaluated were age, age at meno-
pause, other risk factors for endometrial carcinoma,
indications for hysteroscopy, ultrasonographic ﬁndings,
hysteroscopic results, histological diagnosis and follow
up. Risk factors for endometrial carcinoma considered
were: late menopause (occurring after 52 years old),
obesity (body mass index above 30) and diabetes mell-
itus diagnosed previously by a general practitioner and
under therapy with insulin or oral agents.
Patients received premedication with 200 lg of mi-
soprostol vaginally the evening before and 250 mg of
naproxen orally in the morning of procedure. Almost all
patients received a paracervical block with lidocaine 1%.
The procedure was carried out without anaesthesia in
few patients.
Diagnostic and operative outpatient hysteroscopy
was performed with a 5.5 mm rigid continuous ﬂow
hysteroscopic system with 12 or 30 optics (Olympus,
Melville, N.Y., USA), with a ﬁve French working
channel. Hydrodilatation was with normal saline solu-
tion, and operating instruments included scissors, gras-
pers and the bipolar Versapoint device. We used mostly
twizzle electrode for coagulating and cutting. We kept
the input pressure below 100 mmHg. Operating time
was always less than 45 min.
A visual pain scale, graded from 0 to 10, was used
after each procedure. Except for six cases in group 2, all
other surgery involved collection of samples for histo-
logical examination (a total of 229 samples).
Data were recorded and analysed with SPSS12
statistical software: the X2 test for discontinuous
variables and Student’s t-test for continuous variables
were used.
Results
Indications for the 236 hysteroscopies were:
– Ultrasound abnormalities in 150 women (63.6%)
– Uterine bleeding and ultrasound abnormalities in 86
patients (36.4%)
In total, 182 procedures were therapeutic and 54 were
diagnostic: 55 symptomatic patients (64.0%) and 127
asymptomatic patients (84.7%) underwent operative
hysteroscopy, while the remaining patients had diag-
nostic hysteroscopy.
Global mean pain score was 3.2 (0–10), patient tol-
erance was very good and the procedure was not con-
sidered inconclusive in any case.
Population characteristics are presented in Table 1.
Mean age of patients was 65.5±8.1 SD years, between
51 and 87 years. In the overall population 63.2% had at
least one risk factor for endometrial carcinoma.
There was no diﬀerence between two groups regard-
ing age of patients, age at menopause and presence of at
least one of the risk factors for endometrial carcinoma
that we evaluated. Obesity was more frequent in the
symptomatic group (49.2% vs 29.9%) and this diﬀer-
ence has statistical signiﬁcance (P=0.03).
Ultrasonographic features in both groups are dis-
played in Table 2. The commonest abnormality reported
was endometrial thickness, 87.2% and 64%, respec-
tively, in groups 1 and 2. Ultrasound reference of polyp
was more frequent on asymptomatic women (32.6% in
this group vs 11.6% in group 1, P<0.01). The presence
Table 1 Diﬀerences in population characteristics between symptomatic (group 1) and asymptomatic (group 2) women (NS statistically
not signiﬁcant, S statistically signiﬁcant)
Characteristic Group 1 (n=86) Group 2 (n=150) Statistical signiﬁcance
Patients’ mean age (years) 66.4±8.3 SD 64.9±7.97 SD P=0.17 (NS)
Mean age at menopause (years) 49.6±4.1 SD 50.1±3.8 SD P=0.48 (NS)
Presence of at least one risk factor for endometrial cancer 65.7% 61.7% P=0.73 (NS)
Patients with history of late menopause 31.7% 42.2% P=0.23 (NS)
Patients with obesity 49.2% 29.9% P=0.03 (S)
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of ﬁbroid or ﬂuid in the uterine cavity was rarely
reported: six cases in total.
Quantiﬁcation of mean endometrial thickness found
on ultrasound showed no statistical diﬀerence in both
groups (11.6 mm ±6.3 SD in group 1 and
11.0 mm ±4.8 SD in group 2, P=0.56).
Hysteroscopic ﬁndings are shown in Table 3. The
most frequent pathology found was apparently benign
endometrial polyp in both groups. In asymptomatic
women this diagnose reach 84% of cases, whereas, in
women with metrorrhagia, polyps were present in 65.1%
(P<0.01).
Other benign lesions were diagnosed in 10.1% of the
total. The presence of uterine septum occurred only in
asymptomatic women, with a frequency of 4.7%.
Carcinoma was suspected in 19.8% and 1.3% of
patients in groups 1 and 2, respectively (P<0.01). All
cases of suspected carcinoma were conﬁrmed by histo-
logical examination. In 11 cases no lesion was found
(4.7%): six in group 1 and ﬁve in group 2.
Table 4 shows the histological diagnosis obtained
from hysteroscopically collected samples.
In six patients in group 2 no biopsy was per-
formed: three intrauterine adhesions and three uterine
septum.
Histology conﬁrmed the presence of benign polyps in
77.1% of cases: 64.0% and 84.7% in groups 1 and 2,
respectively, this diﬀerence being statistically signiﬁcant
(P<0.01).
Endometrial carcinoma was signiﬁcantly more fre-
quent in symptomatic than asymptomatic women
(23.3% vs 1.3%, P<0.01).
Overall, endometrial carcinoma was diagnosed in 22
women (9.3%). Of these 22 women, 91.3% had had
uterine bleeding. At least one of the risk factors de-
scribed was identiﬁed in 73%. Obesity was found in
61.9% of women with carcinoma in contrast to 34.8%
with benign disease (P=0.03) and was the only risk
factor that was signiﬁcantly diﬀerent. Ultrasonographic
ﬁndings of patients with carcinoma were: diﬀuse endo-
metrial thickness in 17 cases, focal endometrial thickness
in three, polyp and ﬂuid in the uterine cavity in one case
each. The mean endometrial thickness was
14.1 mm ±8.5 SD compared with 10.9 mm ±4.8 SD in
women with benign lesions (P=0.04).
In asymptomatic women the diagnosis of endometrial
hyperplasia and carcinoma was made in 4.0%.
In 5.8% of symptomatic women an atrophic endo-
metrium was the only ﬁnding, whereas, in group 2, this
accounted for 2%.
Table 2 Ultrasonographic ﬁndings reported in the symptomatic (group 1) and asymptomatic (group 2) women (NS statistically not
signiﬁcant, S statistically signiﬁcant)
Finding Group 1 (n=86) Group 2 (n=150) Statistical signiﬁcance Total (n=236)
Endometrial thickness (>4 mm) 75 (87.2%) 96 (64%) P<0.01 (S) 171 (72.5%)
Polyp 10 (11.6%) 49 (32.6%) P<0.01 (S) 59 (25%)
Fibroid 0 1 (0.7%) (NS) 1 (0.4%)
Fluid in uterine cavity 1 (1.2%) 4 (2.7%) (NS) 5 (2.1%)
Table 3 Comparison of
endoscopic pictures between
symptomatic (group 1) and
asymptomatic (group 2) women
(NS statistically not signiﬁcant,
S statistically signiﬁcant)
Endoscopic result Group 1 (n=86) Group 2 (n=150) Statistical signiﬁcance Total (n=236)
Without pathology 6 (7%) 5 (3.3%) (NS) 11 (4.7%)
Benign polyp 56 (65.1%) 126 (84%) P<0.01 (S) 182 (77.1%)
Other benign lesions
Intrauterine adhesion 3 (3.5%) 3 (2.0%) (NS) 6 (2.5%)
Uterine septum 0 7 (4.7%) 7 (3.0%)
Fibroid 2 (2.3%) 4 (2.7%) 6 (2.5%)
Endometritis 0 1 (0.7%) 1 (0.4%)
Hyperplasia 2 (2.3%) 2 (1.3%) (NS) 4 (1.7%)
Carcinoma 17 (19.8%) 2 (1.3%) P<0.01 (S) 19 (8.1%)
Table 4 Histological diagnosis
between symptomatic (group 1)
and asymptomatic (group 2)
women (NS statistically not
signiﬁcant, S statistically
signiﬁcant)
Histology ﬁnding Group 1 (n=86) Group 2 (n=150) Statistical signiﬁcance Total (n=236)
Atrophic endometrium 5 (5.8%) 3 (2.0%) (NS) 8 (3.4%)
Benign polyp 55 (64%) 127 (84.7%) P<0.01 (S) 182 (77.1%)
Other benign lesions 3 (3.5%) 8 (5.3%) (NS) 11 (4.7%)
Hyperplasia 2 (2.3%) 4 (2.7%) (NS) 6 (2.5%)
Endometrial carcinoma 20 (23.3%) 2 (1.3%) P<0.01 (S) 22 (9.3%)
Cervical carcinoma 1 (1.1%) 0 (NS) 1 (0.4%)
No samples 0 6 (4%) (NS) 6 (2.5%)
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Table 5 compares histological results with the endo-
scopic pictures reported. Overall, the hysteroscopic re-
port was correct in 213 (90.3%) cases. Of the total 182
cases of benign polyps in histology, 96.2% were referred
at hysteroscopy (speciﬁcity of 87.0% and sensitivity of
96.2%).
In women with conﬁrmed endometrial hyperplasia
the hysteroscopy pointed to this diagnosis in only two of
the six cases.
All suspected cases of endometrial carcinoma at
hysteroscopy were conﬁrmed, which showed a speciﬁcity
of 100%. In three cases of endometrial carcinoma dif-
ferent ﬁndings were recorded on hysteroscopy (sensi-
tivity of 86.4%): two were referred as benign polyps and
one as hyperplasia.
In ﬁve cases the carcinoma was found inside the
polyp. This accounted for 2.6% of malignancy inside
polyps.
The only case of cervical carcinoma was misdiag-
nosed at hysteroscopy, being reported as endometrial
hyperplasia.
There were no serious complications. We had only
one case of uterine perforation without further conse-
quences in a patient with intrauterine adhesions
(0.04%).
See and treat in one session was achieved in 91% of
cases of benign endometrial polyps.
Overall, 40 women had subsequent surgery under
general anaesthesia (16.9%): four resectoscopies for
endometrial ablation and 36 hysterectomies. Indications
for hysterectomy were: 22 cases for endometrial carci-
noma, seven cases for other gynaecological pathology,
four cases for multiple or recurrent polyps and three
cases for endometrial hyperplasia.1
Discussion
Globally, the population studied revealed the presence
of at least one risk factor for endometrial carcinoma in
63.2%. The only risk factor signiﬁcantly diﬀerent be-
tween the two groups was overweight, present in a high
proportion of women with metrorrhagia (49.2%).
Although endometrial thickness was the abnormality
more diagnosed at ultrasound in both groups, reports
diﬀered in that polyps were more frequently referred in
asymptomatic women (32.6% vs 11.6%, P<0.01). Ul-
trasound endometrial thickness was signiﬁcantly higher
in cases of carcinoma.
Abnormal ultrasound in these women corresponded
mostly to intracavitary disease; absence of organic
endometrial pathology was found in a minority of cases
in both groups (9.3% vs 11.3%).
The pathology most commonly found in both groups
was benign endometrial polyps, but its distribution was
signiﬁcantly diﬀerent: 64% in symptomatic women and
84.7% in asymptomatic women. On the other hand,
endometrial carcinoma was present in 23.3% and 1.3%,
respectively, in the ﬁrst and second group. Of the 22
women with endometrial carcinoma, 20 had metror-
rhagia.
The number of cases with other benign pathology
was similar in both groups, namely endometrial hyper-
plasia.
Hysteroscopy diagnosis revealed an agreement with
histology in 90.3% of cases. Its speciﬁcity and sensitivity
for diagnosis of benign polyps was 87.0% and 96.2%.
For endometrial carcinoma, hysteroscopic speciﬁcity
was 100% and sensitivity 86.4%.
See and treat in one session was achieved for the great
majority of benign endometrial polyps. This high rate of
excisional biopsies was possible due to the use of the
bipolar Versapoint device, which enables easier and
safer operating manoeuvres, allowing a shorter operat-
ing time.
Conclusions
Our results conﬁrmed the good sensitivity and speciﬁcity
for intracavitary pathology, high tolerability and safety
of ambulatory hysteroscopy.
In this study postmenopausal women with metror-
rhagia revealed a higher risk for endometrial carcinoma
than did other references in the literature. These values
make us strongly advise our menopausal patients with
abnormal uterine bleeding to undergo diagnostic hyst-
eroscopy complemented with biopsy.
Asymptomatic women with abnormal transvaginal
ultrasound results revealed a low risk for endometrial
Table 5 Histological results related to endoscopic pictures of all women studied
Histological results Endoscopic pictures
Without pathology Benign polyp Other benign lesions Hyperplasia Carcinoma
Atrophic endometriuma (n=8) 7 1 – – –
Benign polyp (n=182) 4 175 3 – –
Other benign lesions (n=11) – 1 10 – –
Hyperplasia (n=6) – 3 1 2 –
Carcinoma (n=22) – 2 – 1 19
Cervical carcinoma (n=1) – – – 1 –
No samples (n=6) – – 6 – –
Total 11 182 20 4 19
aAtrophic endometrium
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hyperplasia or carcinoma, although organic endometrial
pathology was frequent. Ultrasound seems to be a good
screening method in these women and could be com-
plemented with Doppler studies or sono-hysterography
to achieve a better case selection for hysteroscopy. Per-
forming ambulatory hysteroscopy on these women of-
fers the possibility of accurate diagnosis as well as
treatment in the same session. In our setting, excision of
benign polyps was achieved in the vast majority of cases,
freeing women from serial ultrasound follow up and
psychological burden.
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